Expression of concern: Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma

Biosci Rep. 2021 Feb 26;41(2):BSR-20171001_EOC. doi: 10.1042/BSR-20171001_EOC.
No abstract available

Keywords: CD133; PEG-PLGA nanoparticles; gastric carcinoma; methioninase; pemetrexed; scFV.

Publication types

  • Expression of Concern